on 19 Dec 2023
Last Applicant/ Owned by
620 Memorial Drive
Cambridge
MA
02139
Serial Number
88827351 filed on 09th Mar 2020
Registration Number
7249621 registered on 19th Dec 2023
Correspondent Address
Jonathan M. Gelchinsky
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Scientific research in the fields of nucleic acid pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics Pharmaceuticals for the treatment of cancer, autoimmune, immune mediated, and inflammatory diseases and disorders; nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars, and therapeutics for the treatment of cancer, autoimmune, immune med Read More
Scientific research in the fields of nucleic acid pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics
30th Apr 2023
22nd May 2023
Pharmaceuticals for the treatment of cancer, autoimmune, immune mediated, and inflammatory diseases and disorders; nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars, and therapeutics for the treatment of cancer, autoimmune, immune mediated, immune system related, and inflammatory diseases and disorders; nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars, and therapeutics for the prevention and treatment of viral and infectious diseases; nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars, and therapeutics for therapeutic vaccines
30th Apr 2023
30th Apr 2023
No 88827351
No Service Mark
No 39957/3542OR
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
19th Dec 2023 | REGISTERED-PRINCIPAL REGISTER |
19th Dec 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
14th Nov 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
13th Nov 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
07th Aug 2023 | STATEMENT OF USE PROCESSING COMPLETE |
26th Jul 2023 | TEAS STATEMENT OF USE RECEIVED |
26th Jul 2023 | USE AMENDMENT FILED |
11th Apr 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
10th Apr 2023 | SOU EXTENSION 5 GRANTED |
04th Apr 2023 | TEAS PETITION TO REVIVE RECEIVED |